Discordant results with pimecrolimus 1% cream in the treatment of plasma cell balanitis

Dermatology

Volumn 218, Issue 2, 2009, Pages 155-158

  Stinco, Giuseppe ^a   Piccirillo, Fabio ^a   Patrone, Pasquale ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Balanitis; Calcineurin inhibitors; Side effects; Topical treatment

Indexed keywords

BETAMETHASONE; CLOBETASOL; HYDROCORTISONE; MACROLIDE; PIMECROLIMUS; STEROID; TACROLIMUS;

AGED; ARTICLE; BALANITIS; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BALANITIS; DERMATOLOGIC AGENTS; EMOLLIENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PLASMA CELLS; REPRODUCIBILITY OF RESULTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 59049083235     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000161119     Document Type: Article

References (14)

1. Zoon JJ: Balanoposthite chronique circonscrite bénigne àplasmocytes. Dermatologica 1952;105:1-7.
2. Alessi E, Coggi A, Gianotti R: Review of 120 biopsies performed on the balanopreputial sac: from Zoon's balanitis to the concept of a wider spectrum of inflammatory non-cicatricial balanoposthitis. Dermatology 2004;208:120-124.
3. Moreno-Arias GA, Camps-Fresneda A, Llaberia C, Palou-Almerich J: Plasma cell balanitis treated with tacrolimus 0.1%. Br J Dermatol 2005;153:1204-1206.
4. Hague J, Ilchyshyn A: Successful treatment of Zoon's balanitis with topical tacrolimus. Int J Dermatol 2006;45:1251-1252.
5. Hernandez-Machin B, Hernando LB, Marrero OB, Hernandez B: Plasma cell balanitis of Zoon treated successfully with topical tacrolimus. Clin Exp Dermatol 2005;30:588-589.
6. RoéE, Dalmau J, Peramiquel L, et al: Plasma cell balanitis of Zoon treated with topical tacrolimus 0.1%: report of three cases. J Eur Acad Dermatol Venereol 2007;21:284-285.
7. Santos-Juanes J, Sánchez del Río J, Galache C, Soto J: Topical tacrolimus: an effective therapy for Zoon balanitis. Arch Dermatol 2004;140:1538-1539.
8. Bardazzi F, Antonucci A, Savoia F, Balestri R: Two cases of Zoon's balanitis treated with pimecrolimus 1% cream. Int J Dermatol 2008;47:198-201.
9. Margolis DJ, Hoffstad O, Bilker W: Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007;214:289-295.
10. Langley RG, Luger TA, Cork MJ, et al: An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance. Dermatology 2007;215:27-44.
11. Bohm M, Frieling U, Luger TA, Bonsman G: Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 2003;139:922-924.
12. Georgala S, Gregoriou S, Georgala C, Papaioannou D, Befon A, Kalogeromitros D, Rigopoulos D: Pimecrolimus 1% cream in non-specific inflammatory recurrent balanitis. Dermatology 2007;215:209-212.
13. Zuberbier T, Chong SU, Grunow K, et al: The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 2001;108:275-280.
14. Virgili A, Mantovani L, Lauriola MM, et al: Tacrolimus 0.1% ointment: is it really effective in plasma cell vulvitis? Report of four cases. Dermatology 2008;216:243-246.